VDR gene polymorphism and Dopaminergicand VDR gene expression in Attention Deficit Hyperactivity Disorder (ADHD) - ADHD- Attention Deficit Hyperactivity disorder

Amrita Institute of Medical Sciences and Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1A. Healthy children (Controls): Children with no current medical illness and family history of any major psychiatric disorder, especially ADHD as defined by ICD-10/ DSM-V.
•1B. ADHD patients (Cases): Children diagnosed with ADHD by the paediatrician and the clinical psychologist using the Vanderbilt ADHD rating scale and who are on therapy or not. Comorbid with ODD, SLD, and CD will be included.
•2. Willing to withdraw blood and participate in the study after giving consent.
•3. Responsible caregiver to provide sufficient information about the participant’s functional status.

•1. History of any neurological disorder and psychiatric conditions involving the brain or other central function (eg: History of brain injury, suspected intellectual disability, autism spectrum disorder, narcolepsy, H/O mental retardation (MR), schizophrenia, mania episode, epilepsy, anxiety disorders, bipolar disorder, active suicidal ideation)
•2. Use of Anticoagulants
•3. Having any serious medical condition, including inflammatory bowel disease, history of cancer, kidney or liver disease, hyperthyroidism, glaucoma, diabetes or cardiovascular disorders, gallstones, bile duct obstruction, stomach ulcers, or excess stomach acid, abnormality of mineral metabolism eg: Wilson’s disease, hemochromatosis
•4. Having any disability that would interfere with participation in the study.

发起方

Amrita Institute of Medical Sciences and Research Centre